Neurologic clinical trial - Argenx

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05405361

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy (ARDA+)

Drug

Argx-117

Phase

Phase II

Condition

Multifocal Motor Neuropathy

Keywords

Multifocal Motor Neuropathy, MMN